Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Corbus Pharmaceuticals (CRBP) PT Raised to $36 at Cantor Fitzgerald as Lenabasum's Gain, Following Tocilizumab's Loss
-
UPDATE: Cantor Fitzgerald Starts LHC Group (LHCG) at Overweight
-
UPDATE: Cantor Fitzgerald Starts Amedisys (AMED) at Neutral
-
Foamix (FOMX) Announces Proposed Follow-On Share Offering
-
Foamix Announces Proposed Follow-on Offering of Ordinary Shares
-
Cantor Fitzgerald Starts Addus HomeCare (ADUS) at Overweight
-
Cerner (CERN) Executive Departure 'Not Concerning' - Cantor Fitzgerald
-
Cantor Fitzgerald Maintains Bullish View on PolarityTE (COOL) Post Q3
-
Cantor Fitzgerald Positive on Evolent Health (EVH) New Century Health Acquisition, Raises PT Raised to $37
-
Cantor Fitzgerald Downgrades Vital Therapies (VTL) to Neutral
-
Pacific Bio (PACB) Prices 14.12M Share Common Offering at $4.25/Sh
-
Pacific Biosciences of California, Inc. Announces Pricing of Public Offering of Common Stock
-
Pacific Biosciences of California, Inc. Announces Pricing of Public Offering of Common Stock
-
Emergent BioSolutions (EBS) PT Raised to $68 at Cantor Fitzgerald
-
PCI Pharma Services to Acquire Sherpa Clinical Packaging
-
Advaxis Announces Closing of Its Public Offering of Common Stock and Warrants
-
Cantor Fitzgerald Starts Krystal Biotech (KRYS) at Overweight
-
Pacific Bio (PACB) Proposed Public Offering of Common Stock
-
Pacific Biosciences of California, Inc. Announces Proposed Public Offering of Common Stock
-
Pacific Biosciences of California, Inc. Announces Proposed Public Offering of Common Stock
-
KalVista Pharmaceuticals Announces the Closing of its Public Offering of Common Stock and Full Exercise of the Underwriters’ Over-allotment Option to Purchase Additional Shares
-
Ideanomics Appoints Brett McGonegal Co-CEO, adds other Senior Executives
-
"Instant Family" Actress, Rose Byrne, to Represent Happy Trails for Kids at 2018 Cantor Fitzgerald Charity Day
-
Cantor Fitzgerald Starts Aridis Pharmaceuticals (ARDS) at Overweight
-
Global Lyme Alliance to Participate in 2018 Cantor Fitzgerald Charity Day
-
Quality Systems (QSII) PT Raised to $26 at Cantor Fitzgerald
-
Advaxis (ADXS) Prices 16.67M Shares Offering
-
Pre-Open Movers 09/07: (OKTA) (FIVE) (MRVL) Higher; (EGAN) (TSLA) (HOME) Lower (more...)
-
Advaxis Announces Pricing of Its Public Offering of Common Stock and Warrants
-
ProPhotonix Limited Announces Interim Results
-
Mizuho Hires Senior Corporate and Investment Bankers to Enhance its Consumer Sector Coverage and Financial Sponsors Business
-
Mizuho Hires Senior Corporate and Investment Bankers to Enhance its Consumer Sector Coverage and Financial Sponsors Business
-
Advaxis (ADXS) Announces Proposed Offering of Common Shares & Warrants
-
Advaxis, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Warrants
-
After-Hours Stock Movers 09/06: (OKTA) (FNSR) (FIVE) Higher; (EGAN) (MNLO) (HOME) Lower (more...)
-
Cantor Fitzgerald Starts Tabula Rasa Healthcare (TRHC) at Overweight
-
Cantor Fitzgerald Starts Menlo Therapeutics (MNLO) at Overweight
-
KalVista Pharmaceuticals (KALV) Prices 4M Share Common Offering at $17/Sh
-
KalVista Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
KalVista Pharmaceuticals (KALV) Announces Proposed Common Share Offering
-
KalVista Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
Nuvectra to Participate in Two Upcoming Investor Conferences
-
Dermira (DERM) Moving Ahead on All Commercial Efforts Says Cantor
-
Coupa Software (COUP) PT Raised to $92 at Cantor Fitzgerald
-
HealthEquity, Inc (HQy) PT Raised to $80 at Cantor Fitzgerald
-
Luxoft Holding (LXFT) PT Raised to $52 at Cantor Fitzgerald
-
Cantor Fitzgerald Downgrades K2M Group Holdings (KTWO) to Neutral
-
Longevity Acquisition Corporation Announces Closing of $40,000,000 Initial Public Offering
-
Longevity Acquisition Corporation Announces Closing of $40,000,000 Initial Public Offering
-
MannKind Corporation to Present at Upcoming Conferences


